ADAR1 Capital Management »

Cybin shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Cybin (HELP) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Cybin

Tip: Access up to 7 years of quarterly data

All positions including Cybin held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cybin by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $196k 33k 5.89

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Keros Therapeutics (KROS)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Immunovant (IMVT)
89bio (ETNB)
Zai Lab Adr (ZLAB)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Uniqure Nv SHS (QURE)
Prothena Corp SHS (PRTA)
Bridgebio Pharma (BBIO)
Arbutus Biopharma (ABUS)

View all positions for ADAR1 Capital Management

Top funds holding Cybin

Tang Capital Management
Rosalind Advisors
Point72 Asset Management
Deep Track Capital
Acorn Capital Advisors
Susquehanna International
Sphera Funds Management
DLD Asset Management
Stonepine Capital Management
UBS Group
Citadel Advisors
Pale Fire Capital SE
BlackRock
Ikarian Capital
Knott David M Jr

View all funds holding Cybin